A61P 25/26
Psychostimulants
Official title: Psychostimulants, e.g. nicotine, cocaine
A61P25/26 (Psychostimulants) appears on 2,098 US grants and 1,300 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,098
- Published applications
- 1,300
- Assignees
- 757
- Inventors
- 4,210
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 25 | 0 |
| 1977 | 15 | 0 |
| 1978 | 32 | 0 |
| 1979 | 29 | 0 |
| 1980 | 38 | 0 |
| 1981 | 41 | 0 |
| 1982 | 35 | 0 |
| 1983 | 20 | 0 |
| 1984 | 25 | 0 |
| 1985 | 40 | 0 |
| 1986 | 41 | 0 |
| 1987 | 38 | 0 |
| 1988 | 48 | 0 |
| 1989 | 65 | 0 |
| 1990 | 63 | 0 |
| 1991 | 55 | 0 |
| 1992 | 51 | 0 |
| 1993 | 64 | 0 |
| 1994 | 59 | 0 |
| 1995 | 64 | 0 |
| 1996 | 81 | 0 |
| 1997 | 145 | 0 |
| 1998 | 101 | 0 |
| 1999 | 75 | 0 |
| 2000 | 54 | 0 |
| 2001 | 48 | 8 |
| 2002 | 37 | 37 |
| 2003 | 24 | 50 |
| 2004 | 17 | 49 |
| 2005 | 26 | 46 |
| 2006 | 18 | 38 |
| 2007 | 21 | 50 |
| 2008 | 25 | 56 |
| 2009 | 19 | 99 |
| 2010 | 40 | 80 |
| 2011 | 37 | 72 |
| 2012 | 47 | 52 |
| 2013 | 41 | 60 |
| 2014 | 49 | 60 |
| 2015 | 39 | 60 |
| 2016 | 22 | 47 |
| 2017 | 49 | 45 |
| 2018 | 23 | 52 |
| 2019 | 43 | 57 |
| 2020 | 43 | 54 |
| 2021 | 30 | 48 |
| 2022 | 22 | 40 |
| 2023 | 23 | 40 |
| 2024 | 24 | 46 |
| 2025 | 20 | 33 |
| 2026 | 7 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Advanced glycation end product analogues18 Aug 2026US 12,709,630 B2Phytoquest Limited
- Heterocyclic compound and use thereof23 Jun 2026US 12,662,453 B2Takeda Pharmaceutical Company Limited
- Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P4507 Apr 2026US 12,594,269 B2Takeda Pharmaceutical Company Limited
- Oral solutions comprising lisdexamfetamine salts24 Mar 2026US 12,582,620 B2Adalvo Limited
- Stimulant composition and process for making same24 Mar 2026US 12,582,659 B2All Labs, Inc.
- Oral composition comprising l-theanine17 Sep 2026US 2026/0272869 A1Nicoventures Trading Limited
- R-mdma and s-mdma to assist psychotherapy20 Aug 2026US 2026/0240806 A1Universitätsspital Basel
- Methods and compositions for improving driving performance16 Jul 2026US 2026/0199282 A1Axsome Therapeutics, Inc.
- Oral Solutions Comprising Lisdexamfetamine Salts2 Jul 2026US 2026/0183252 A1Adalvo Limited
- Compositions and formulations for creating mental and physical energy18 Jun 2026US 2026/0166043 A1Korrect Life, LLC
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Controlled release bases for pharmaceuticals383US 4,861,598 AEuroceltique, S.A. · 1989
- Abuse-proofed dosage system297US 7,776,314 B2GrüNenthal GmbH · 2010